miR-27b synergizes with anticancer drugs via p53 activation and CYPIB1 suppression

Liver and kidney cancers are notorious for drug resistance. Due to the complexity, redundancy and interpatient heterogeneity of resistance mechanisms, most efforts targeting a single pathway were unsuccessful. Novel personalized therapies targeting multiple essential drug resistance pathways in para...

Full description

Saved in:
Bibliographic Details
Published in细胞研究:英文版 no. 4; pp. 477 - 495
Main Author Wenjing Mu Chaobo Hu Haibin Zhang Zengqiang Qu Jin Cen Zhixin Qiu Chao Li Haozhen Ren Yixue Li Xianghuo He Xiaolei Shi Lijian Hui
Format Journal Article
LanguageEnglish
Published 2015
Subjects
Online AccessGet full text

Cover

Loading…